Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mindfulness-based attentional control refers to the capacity to flexibly, deliberately, and non-judgmentally focus, shift, and sustain attention on present-moment experiences, cultivated via mindfulness training and meditation. It encompasses multiple attentional networks: alerting (preparedness), orienting (selective attention), and executive/conflict control (suppression of irrelevant stimuli). This form of attentional control is associated with improved self-regulation, better performance in attention tasks, and enhanced well-being. Effects are observed through behavioral improvements, as well as measurable changes in neural activity via EEG and fMRI, following regular mindfulness practice[1][2][3][4]. It is not a molecular receptor or classic pharmacological target, but a neurocognitive skill developed through sustained mental training.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mindfulness-based attentional control.